Abivax SA American Depositary Shares (ABVX)

Abivax SA American Depositary Shares (ABVX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $7.7B; returns 1 day -2.5%, 1 week -0.1%, 1 year -2.7%.

Abivax SA is a clinical-stage biotechnology company focused on developing innovative therapeutics that leverage the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.

Groups ABVX belongs to

• Biotechnology
• Clinical Stage Biotech
• Chronic Inflammatory Diseases
• Clinical Stage
• Healthcare
• Gastroenterology
• Biopharmaceutical
• Pharmaceuticals
• Life Sciences

ABVX financial model: income statement, cash flow and balance sheet